Trading Members of the Exchange are hereby informed that effective from Wednesday, August 21, 2024, the Equity Shares of BROACH LIFECARE HOSPITAL LIMITED shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.
Name of the company
|
BROACH LIFECARE HOSPITAL LIMITED
|
Registered Office:
|
Address: 501 5th Floor Corporate House above Bharuch Orthopedic Hospital R K Casta
Bharuch Gujrat 392001 India
392001
Tel: +91 94291 87226
Email: info@maplehospital.in
Website: www.maplehospital.in
|
No. of Securities
|
6070380 Equity Shares of Rs.10/- each fully paid up
|
Distinctive Number range
|
1 To 6070380
|
Scrip ID on BOLT System
|
BROACH
|
Abbreviated Name on BOLT System
|
BROACH
|
Scrip Code
|
544231
|
ISIN No.
|
INE0SFZ01018
|
Market Lot
|
6000
|
Issue Price for the current Public issue
|
Rs. 25/- per share (Face Value of Rs. 10/- and premium of Rs. 15/-)
|
Date of Allotment in the public issue:
|
August 19, 2024
|
Pari Pasu
|
Yes
|
Financial Year
|
Mar-31
|
Lock in detail
|
As per Annexure I
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e.6000equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.
b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Wednesday, August 21, 2024. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c) The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depositorys records.
d) The Market Maker to the issue as mentioned in the prospectus is given below:
Name of Market Maker: Aftertrade Broking Private Limited (formerly known as RCSPL Share Broking Private Limited)
Address - 206, 2nd floor, Time Square, Beside Pariseema Complex, C G Road, Navrangpura, Ahmedabad – 380009.
Tel no. 7801918080
Email ID compliance@aftertrade.in
Website www.aftertrade.in
Investor Grievance ID - compliance@aftertrade.in
Contact person: Tanmay Trivedi
Sebi Registration no. INZ000155638
|
e) The Registrar to the issue as mentioned in the prospectus is given below
KFIN TECHNOLOGIES LIMITED
Address: Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally, Hyderabad – 500 032, Telangana, India.
Telephone: +91 4067162222
E-mail: blhl.ipo@kfintech.com
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
Investor Grievance E-Mail: einward.ris@kfintech.com
|
f) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
a) At the company:
Mrs. Swati Sharma
Company Secretary and Compliance Officer
|
Address: 501 5th Floor Corporate House above Bharuch Orthopedic Hospital R K Casta
Bharuch Gujrat 392001 India
392001
Tel:+91 94291 87226
Email: info@maplehospital.in
Website: www.maplehospital.in
|
b) At the Exchange:
Mr. Prasad Bhide
Senior Manager
|
Tel.: (91) 022 2272 8388
|
Mr. Prasad Bhide
Senior Manager
Tuesday, August 20,2024
|